Preferred Label : Substance;

NCIt definition : Any matter of defined composition that has discrete existence, whose origin may be biological, mineral or chemical.;

Details


Main resources

You can consult :


https://www.ofdt.fr/publications/collections/resultats/les-usages-de-substances-psychoactives-chez-les-collegiens-et-lyceens-resultats-enclass-2022/
2024
France
technical report
Substance
resulting in
culture
psychotropic drugs
students

---
https://www.ofdt.fr/publication/2024/les-usages-de-substances-psychoactives-chez-les-adolescents-en-outre-mer-2102
2024
France
technical report
adolescence
Repeat Unit
Teenager
culture
MERTK wt Allele
Staphylococcal Enterotoxin A
Substance
G-Protein Coupled Estrogen Receptor 1
Adolescent Mothers
Adolescent
SEA Mouse
Adolescents
GPER1 wt Allele
psychotropic drugs

---
https://minerva-ebp.be/FR/Analysis/867
2024
Belgium
critical appraisal or critical reading
economics
Catenin Delta-1
Packaging Case
motivational interviewing
Motivational Interviewing
Case Dosing Unit
CTNND1 wt Allele
Substance
Coronavirus Anxiety Scale
No Cases Transmission Pattern
BCAR1 wt Allele
Case
True Case Status
Breast Cancer Anti-Estrogen Resistance Protein 1
snacks

---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101204/n/exposition-professionnelle-femmes-substances-chimiques
2024
Canada
technical report
effects of exposure to external cause, nos
Specified
Chemical Exposure
C-C Motif Chemokine 7
Matrix Device
Substance
Fogarty International Center
Be
Enhance
Gender
employment
specific
CDISC SDTM Sex of Individual Terminology
unemployment
sex ratio
Ratio
templates, genetic
albumin/globulin ratio
Improved
Designated
extracellular matrix
occupational exposure
sex
women
GDC Gender Terminology
Regulatory Report
Statistical Estimation
Matrix Dosing Unit
Unemployed
CCL7 wt Allele
Provide
Occupational Exposure
Respect
Abstracting
Fentanyl
appraiser
Designated Blood Product Donation
Estimate
Woman

---
https://www.anses.fr/fr/content/pfas-des-substances-chimiques-persistantes
2024
France
popular works
Persistent
Very
Substance

---
https://drogues-sante-societe.ca/prevention-des-risques-lies-a-la-consommation-de-substances-en-contextes-festifs-universitaires/
2024
Canada
journal article
Substance
Prevention Study
economics
Preventive Intervention
Application Context
risk
Prevention
Academia

---
https://www.health.belgium.be/fr/avis-9754-ar-interdiction-dexportation-de-substances-dangereuses
2023
Belgium
technical report
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
No History of Non-Cardiac Surgery
Nitric Oxide Measurement
ERBB2 Mutation Analysis Was Not Performed
Negation
ATRX Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
Certain
Unemployed
No History of Neonatal Complication
Some
PTEN Mutation Analysis Was Not Performed
hazardous substances
Minor Criteria for Rheumatic Heart Disease Not Present
Chief Complaint Not Caused by Trauma
Extremity Part
Radiation Therapy Not Received
MGMT Promoter Methylation Testing Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
NRAS Mutation Analysis Was Not Performed
Version
Documentation Absent
Murine Limb
Projected
BRAF Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
CDISC SEND Country Terminology
ATRX Gene Mutation Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Gestational Complication
10q23/PTEN Locus Deletion Analysis Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Paraneoplastic Syndrome is Not Present
Chief Complaint was Not Witnessed
Export
PTEN Gene Mutation Negative
Tumor Reoccurrence Absent After Initial Treatment
TP53 Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
No History of Congenital Heart Disease
Any Metastatic Diagnosis Absent
all extremities
First Degree Family History Cancer Negative
european union
Other Preoperative IV Medications were not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
History of Colorectal Cancer Negative
First Degree Family History of Primary Brain Tumor Negative
Caffeine Not Routinely Consumed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Projection
Adjuvant I-131 Therapy Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Substance
Medication Not Taken
Hypertension Absent
Chemotherapy Not Received
Evidence of Disease Absent after Completion of Therapy
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
SDH Complex Mutation Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Chemical/Occupational Exposure Absent
extremities
Cancer History Absent
EGFR Amplification Analysis Was Not Performed
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No Response to Intervention for Kawasaki Disease
History of Medical Treatment Absent
KRAS Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
No History of Kawasaki Disease
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Neither Case or Control Status
Routine Cytogenetics Were not Completed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Disease is not Multifocal
Nitric Oxide
No History of Myopathy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Adverse Event Definitely Related to Intervention
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
Radiation History Negative
Preoperative IV Opiates were not Administered
MET Mutation Analysis Was Not Performed
Neither
Therapeutic Ionizing Radiation to Head History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
Additional Surgery for New Tumor Event Absent
No History of Rheumatic Fever
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Membership
Country Code
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Family History of Stomach Cancer Absent
Netherlands
1p/19q Deletion Analysis Was Not Performed
Has No Sibling
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Norway
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
NF1 Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Preoperative IV Sedation was Not Administered
ROS1 Rearrangement Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Tumor Progression Absent After Initial Treatment
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Physician Diagnosed Diabetes Absent
Preoperative IV Antacids were not Administered
EGFR Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Additional Molecular Studies Were Not Performed
Preoperative IV Antiemetics were not Administered
Discontinue
Adjuvant Post-operative Immunological Therapy Was Not Administered
European Union
EGFR Gene Amplification Negative
Additional Immunohistochemistry Was Not Performed
IDH Family Mutation Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use

---
https://www.ofdt.fr/publications/collections/tendances/substances-psychoactives-usagers-et-marches-tendances-en-2022-tendances-160-decembre-2023/
2023
France
journal article
Markup
Trends
Marketing
Over the Counter Product
psychotropic drugs
Substance
SLC5A8 wt Allele
gait, nos
Walking

---
https://www.anses.fr/fr/system/files/VSR2019SA0202Ra.pdf
2023
France
technical report
research report
family relations
Family Study
dataset
albumin/globulin ratio
Substance
Household
No Information Available
Ratio
judgment
Neither Agree or Disagree
inlets
Data Set
Relative Value
family
succinate dehydrogenase
family, nos
succinate
succinate dehydrogenase
bays
Data
Regulatory Report

---
https://www.inrs.fr/media.html?refINRS=Anim-389
2023
France
video recording
Work
Worksite
Application Method of Administration
Application
work
Exhibition
attention
Computer Job
Occupation
Application
effects of exposure to external cause, nos
Chemical Exposure
Computer Application
occupation, nos
Substance

---
https://dumas.ccsd.cnrs.fr/dumas-04200445
2023
France
dissertations, academic
Drug Tolerance
Meta-Analysis
alcohols
Ethanol Measurement
Ethanol
Data Driven Analysis
Treatment
Therapeutic Procedure
Scientific Equipment
Retrospective Study
Substance
Attributable, Legible, Contemporaneous, Original, Accurate
Immunologic Tolerance
retrospective studies
Alcohol
Disease or Disorder
tool, nos
meta-analysis as topic
Tolerance
Meta-Analysis
Attributable, Legible, Contemporaneous, Original, Accurate Plus
alcohol, nos
alcoholics
Therapeutic
hallucinogens
alcoholism
therapeutics
tolerance, nos
Tool
Data Analysis
Tolerability Study
ethyl alcohol
Usage

---
Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.